Immunological features of patients with metastatic uveal melanoma during treatment with pembrolizumab
Latest Information Update: 22 Jul 2019
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Uveal melanoma
- Focus Pharmacodynamics; Therapeutic Use
Most Recent Events
- 01 Jul 2019 Preliminary results (n=17, enrolled between January 2016 to April 2018) published in the Cancer Immunology Immunotherapy
- 10 Jun 2019 New trial record
- 04 Jun 2019 Results presented at the 55th Annual Meeting of the American Society of Clinical Oncology